Actively Recruiting

Phase Not Applicable
Age: 18Years - 75Years
All Genders
NCT04121806

Diet Intervention Treatment for Active Ulcerative Colitis

Led by Mount Sinai Hospital, Canada · Updated on 2025-09-29

20

Participants Needed

1

Research Sites

291 weeks

Total Duration

On this page

Sponsors

M

Mount Sinai Hospital, Canada

Lead Sponsor

N

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborating Sponsor

AI-Summary

What this Trial Is About

The purpose of this study is to determine if a sustainable non-elemental diet can be used as a probiotic tool to alter the dysbiotic microbiome found in individuals with ulcerative colitis and thereby decrease disease activity.

CONDITIONS

Official Title

Diet Intervention Treatment for Active Ulcerative Colitis

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Females and males between 18 and 75 years old at enrollment
  • Established diagnosis of ulcerative colitis by standard endoscopic, radiographic, or histological criteria
  • Active ulcerative colitis with Mayo score of 2 or greater within two months prior to enrollment
  • History of ulcerative colitis affecting more than 10 cm of the colon
  • Fecal calprotectin (FCP) greater than 250 or active endoscopy within 6 months
  • If a smoker, no change in smoking habits during the study
  • Stable medical therapy with no changes 4 weeks before and during the study
Not Eligible

You will not qualify if you...

  • Uncontrolled inflammation likely requiring surgery or therapy escalation within 4 weeks of enrollment
  • Pregnant or lactating females
  • Allergy or intolerance to major components of the study diet
  • Current use of NSAIDs
  • Diagnosed with primary sclerosing cholangitis (PSC)
  • Using topical therapies or suppositories
  • Antibiotic use within 4 weeks before or during the study
  • Confirmed Clostridium difficile infection within 3 months before recruitment
  • History of dysplasia or colorectal cancer

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Mount Sinai Hospital

Toronto, Ontario, Canada, M5G 1X5

Actively Recruiting

Loading map...

Research Team

J

Jenny Lee

CONTACT

J

Joanne Stempak

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here